Clinical Trial Update: Neuromodulation Therapy Device for the Treatment of Sleep Apnea [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a neuromodulation therapy device for obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Snippet

Sponsor: Mayo Clinic | Conditions: Obstructive Sleep Apnea | Phase 1 | Status: COMPLETED